
PIK-293
CAS No. 900185-01-5
PIK-293( PIK-293 | PIK 293 | PIK293 )
Catalog No. M17650 CAS No. 900185-01-5
PIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 67 | In Stock |
![]() ![]() |
5MG | 110 | In Stock |
![]() ![]() |
10MG | 177 | In Stock |
![]() ![]() |
25MG | 312 | In Stock |
![]() ![]() |
50MG | 464 | In Stock |
![]() ![]() |
100MG | 662 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePIK-293
-
NoteResearch use only, not for human use.
-
Brief DescriptionPIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
-
DescriptionPIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
-
In Vitro——
-
In Vivo——
-
SynonymsPIK-293 | PIK 293 | PIK293
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
Recptorp110α| p110β| p110γ| p110δ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number900185-01-5
-
Formula Weight397.43
-
Molecular FormulaC22H19N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (125.81 mM)
-
SMILESCc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(cn1)c(ncn2)N
-
Chemical Name2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Knight ZA et al. Cell, 2006, 125(4), 733-747.
molnova catalog



related products
-
d-Epigalbacin
d-Epigalbacin is a naturally occurring lignin. d-Epigalbacin is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively.
-
AS601245.2TFA
AS601245.2TFA is a cell-permeable Inhibitor of JNK (IC50s of 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively).
-
JNK-IN-11
JNK-IN-11 (compound 1) is a potent inhibitor of JNK, with IC50 values of 2.2 μM, 21.4 μM, and 1.8 μM for JNK1, JNK2, and JNK3, respectively, showing potential for Alzheimer's and Parkinson's disease research.